Anzeige
Mehr »
Freitag, 17.04.2026 - Börsentäglich über 12.000 News
Deutliche Überlegenheit der Erzgehalte: Die Zahlen lügen nicht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
21:10Zymeworks Inc.: Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform71Six poster presentations showcase Zymeworks' next-generation ADC programs, including multiple first-in-class pan-RAS inhibitor ADCs Data highlight efficacy, tumor-selective delivery, and favorable tolerability...
► Artikel lesen
21:06Zai Lab Limited: Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas97 Zoci, a potential first-in-class DLL3-targeting antibody drug conjugate, showed a 53.7% confirmed intracranial objective response rate (iORR) for small cell lung cancer (SCLC) with brain metastases...
► Artikel lesen
21:02Moderna, Inc.: Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting124The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of checkpoint inhibitor refractory unresectable or metastatic melanoma with PD-L1+ (TPS>1%)...
► Artikel lesen
20:18Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst3
19:26Jim Cramer on Gilead Sciences: "I'd Hold On to It"5
19:10Can Myqorzo Drive Growth for Cytokinetics Amid Competition?4
19:10DNLI Gains 25.4% Year to Date: Should You Buy, Sell or Hold the Stock?2
17:22Genmab schließt Kapitalherabsetzung um 1,9 Millionen Aktien ab5
17:18Genmab completes share capital reduction of 1.9 million shares2
17:08XETR DELETION OF INSTRUMENTS FROM XETRA - 17.04.2026 -2-359The following instruments on XETRA do have their last trading day on 17.04.2026.Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 17.04.2026.ISIN Name US5719032022 Marriott International...
► Artikel lesen
17:06XETR DELETION OF INSTRUMENTS FROM XETRA - 17.04.2026 -1-344The following instruments on XETRA do have their last trading day on 17.04.2026.Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 17.04.2026.ISIN Name US0028962076 Abercrombie &...
► Artikel lesen
17:00Genmab A/S Share Capital Reduction110Company Announcement COPENHAGEN, Denmark; April 17, 2026 - Genmab A/S (Nasdaq: GMAB) At Genmab A/S' Annual General Meeting on March 19, 2026, it was decided to reduce the Company's share capital with...
► Artikel lesen
16:54UBS reiterates Buy on Summit Therapeutics stock ahead of trial data1
16:54Weekly Buzz: FDA Okays Travere Therapeutics, Royal Philips; Rejects Replimune; American Industrial Partners Snaps Up Avanos Medical; PDS Biotechnology, Hoth Therapeutics, Spyre Therapeutics, Paces Trials348INDIANAPOLIS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Taiwan, and Europe, alongside FDA rejections, collaborations, acquisitions, and positive...
► Artikel lesen
16:42Kura Oncology Advances Kidney Cancer Program With Solid Early-Stage Results2
16:30EXKLUSIV zu Curevac: Was Insider vor dem Wochenende bereits wissen - Was das für Ihr Depot bedeutet
16:26Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability7
16:26Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision6
16:26Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus4
16:26Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions1
Weiter >>